Keppra and Disseminated intravascular coagulation - from FDA reports


Summary

Disseminated intravascular coagulation is found among people who take Keppra, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Lamictal, and have Preventive health care. This review analyzes which people have Disseminated intravascular coagulation with Keppra. It is created by eHealthMe based on reports of 37,835 people who have side effects when taking Keppra from FDA , and is updated regularly.

What to expect?

If you take Keppra and have Disseminated intravascular coagulation, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Keppra and have Disseminated intravascular coagulation

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 08, 2017

37,835 people reported to have side effects when taking Keppra.
Among them, 55 people (0.15%) have Disseminated intravascular coagulation


Number of reports submitted per year:

Could Keppra cause Disseminated intravascular coagulation?

Time on Keppra when people have Disseminated intravascular coagulation *:

  • < 1 month: 47.06 %
  • 1 - 6 months: 23.53 %
  • 6 - 12 months: 11.76 %
  • 1 - 2 years: 17.65 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Disseminated intravascular coagulation when taking Keppra *:

  • female: 47.17 %
  • male: 52.83 %

Age of people who have Disseminated intravascular coagulation when taking Keppra *:

  • 0-1: 0.0 %
  • 2-9: 2.08 %
  • 10-19: 12.5 %
  • 20-29: 16.67 %
  • 30-39: 16.67 %
  • 40-49: 4.17 %
  • 50-59: 10.42 %
  • 60+: 37.5 %

Top conditions involved for these people *:

  • Preventive Health Care (9 people, 16.36%)
  • Glioblastoma Multiforme (8 people, 14.55%)
  • Depression (5 people, 9.09%)
  • Constipation (3 people, 5.45%)
  • Acute Promyelocytic Leukaemia (3 people, 5.45%)

Top co-used drugs for these people *:

  • Lamictal (12 people, 21.82%)
  • Tegretol (9 people, 16.36%)
  • Protonix (8 people, 14.55%)
  • Simvastatin (6 people, 10.91%)
  • Depakene (6 people, 10.91%)

Top other side effects for these people *:

  • Fever (17 people, 30.91%)
  • Status Epilepticus (12 people, 21.82%)
  • Rhabdomyolysis (12 people, 21.82%)
  • Thrombocytopenia (11 people, 20.00%)
  • Rashes (11 people, 20.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Disseminated intravascular coagulation when taking Keppra?

Expand the study to include all drugs with the same ingredients

Disseminated intravascular coagulation and drugs with ingredients of levetiracetam.

Expand the study to include reports from both FDA and eHealthMe

Disseminated intravascular coagulation and Keppra from FDA and eHealthMe reports

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 40,439 users)

Disseminated intravascular coagulation

Disseminated intravascular coagulation (systemic activation of blood coagulation) has been reported by people with rheumatoid arthritis, preventive health care, high blood pressure, pain, insomnia (latest reports from 17,516 Disseminated intravascular coagulation patients).

Browse all side effects of Keppra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Disseminated intravascular coagulation

Disseminated intravascular coagulation

Could your condition cause Disseminated intravascular coagulation

Disseminated intravascular coagulation

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Keppra and have Disseminated intravascular coagulation.

Questions to the study

More questions >

User reviews to the study

More reviews >